HIGH Share Price Performance
€3.39
-1.66 (-32.87%)
Price €3.39
Share Pricen/a
An Intrinsic Calculation For Cantourage Group SE (ETR:HIGH) Suggests It's 32% Undervalued
Dec 24
Cantourage Group SE Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
HIGH Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Cantourage Group SE Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.0077
- 100.00%
- -4.89%
- 0%
About HIGH
- Founded
- 2019
- Employees
- 7
- CEO
- WebsiteView website
Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.
